These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25505723)

  • 1. Esophgeal Perforation and Bilateral Empyema Following Endoscopic EsophyX Transoral Incisionless Fundoplication.
    Edriss H; El-Bakush A; Nugent K
    Clin Endosc; 2014 Nov; 47(6):560-3. PubMed ID: 25505723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transoral incisionless fundoplication does not significantly increase morbidity of subsequent laparoscopic Nissen fundoplication.
    Perry KA; Linn JG; Eakin JL; Onders RP; Velanovich V; Melvin WS
    J Laparoendosc Adv Surg Tech A; 2013 May; 23(5):456-8. PubMed ID: 23578416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study.
    Cadière GB; Buset M; Muls V; Rajan A; Rösch T; Eckardt AJ; Weerts J; Bastens B; Costamagna G; Marchese M; Louis H; Mana F; Sermon F; Gawlicka AK; Daniel MA; Devière J
    World J Surg; 2008 Aug; 32(8):1676-88. PubMed ID: 18443855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.
    Testoni PA; Testoni S; Mazzoleni G; Vailati C; Passaretti S
    Surg Endosc; 2015 Sep; 29(9):2770-80. PubMed ID: 25480624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transoral Incisionless Fundoplication TIF 2.0 with "EsophyX Z®" Device for GERD: Seven Years after Endo Lumenal Fundoplication. World’s First Case Report.
    Nicolau AE; Lobonţiu A
    Chirurgia (Bucur); 2018; 113(6):849-856. PubMed ID: 30596372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.
    Testoni PA; Vailati C; Testoni S; Corsetti M
    Surg Endosc; 2012 May; 26(5):1425-35. PubMed ID: 22170317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.
    Janu P; Shughoury AB; Venkat K; Hurwich D; Galouzis T; Siatras J; Streeter D; Korman K; Mavrelis G; Mavrelis P
    Surg Innov; 2019 Dec; 26(6):675-686. PubMed ID: 31431138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of second-generation transoral incisionless fundoplication on atypical GERD symptoms: a systematic review and meta-analysis.
    Haseeb M; Brown JRG; Hayat U; Bay C; Bain PA; Jirapinyo P; Thompson CC
    Gastrointest Endosc; 2023 Mar; 97(3):394-406.e2. PubMed ID: 36402203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transoral incisionless fundoplication for recurrent symptoms after laparoscopic fundoplication.
    Ghosh G; Choi AY; Dbouk M; Greenberg J; Zarnegar R; Murray M; Janu P; Thosani N; Dayyeh BKA; Diehl D; Nguyen NT; Chang KJ; Canto MI; Sharaiha R;
    Surg Endosc; 2023 May; 37(5):3701-3709. PubMed ID: 36650353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial.
    Trad KS; Barnes WE; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Turgeon DG; Fox MA
    Surg Innov; 2015 Feb; 22(1):26-40. PubMed ID: 24756976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis.
    Huang X; Chen S; Zhao H; Zeng X; Lian J; Tseng Y; Chen J
    Surg Endosc; 2017 Mar; 31(3):1032-1044. PubMed ID: 27495332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and patient satisfaction of single-session transoral incisionless fundoplication and laparoscopic hernia repair.
    Gisi C; Wang K; Khan F; Reicher S; Hou L; Fuller C; Sattler J; Eysselein V
    Surg Endosc; 2021 Feb; 35(2):921-927. PubMed ID: 32691205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device.
    Jobe BA; O'Rourke RW; McMahon BP; Gravesen F; Lorenzo C; Hunter JG; Bronner M; Kraemer SJ
    Ann Surg; 2008 Jul; 248(1):69-76. PubMed ID: 18580209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
    Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
    Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD.
    Håkansson B; Montgomery M; Cadiere GB; Rajan A; Bruley des Varannes S; Lerhun M; Coron E; Tack J; Bischops R; Thorell A; Arnelo U; Lundell L
    Aliment Pharmacol Ther; 2015 Dec; 42(11-12):1261-70. PubMed ID: 26463242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.
    Bell RC; Mavrelis PG; Barnes WE; Dargis D; Carter BJ; Hoddinott KM; Sewell RW; Trad KS; DaCosta Gill B; Ihde GM
    J Am Coll Surg; 2012 Dec; 215(6):794-809. PubMed ID: 22939637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.
    Trad KS; Barnes WE; Prevou ER; Simoni G; Steffen JA; Shughoury AB; Raza M; Heise JA; Fox MA; Mavrelis PG
    Surg Innov; 2018 Apr; 25(2):149-157. PubMed ID: 29405886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transoral incisionless fundoplication with an ultrasonic surgical endostapler for the treatment of gastroesophageal reflux disease: 12-month outcomes.
    Testoni PA; Testoni S; Mazzoleni G; Pantaleo G; Cilona MB; Distefano G; Fanti L; Antonelli M; Passaretti S
    Endoscopy; 2020 Jun; 52(6):469-473. PubMed ID: 32187630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.